Domača stranAPN • JSE
add
Aspen Pharmacare Holdings Ltd
Prejšnji trg. dan.
16.953,00 ZAC
Dnevni razpon
16.800,00 ZAC - 17.048,00 ZAC
Letni razpon
16.310,00 ZAC - 25.296,00 ZAC
Tržna kapitalizacija
75,47 mrd. ZAR
Povprečni obseg
1,38 mio.
Razm. P/E
17,06
Dividendna donosnost
2,12 %
Primarna borza
JSE
Borzne novice
FXStreet
pred 4 urami
Elliott Wave analysis: SP500, NASDAQ 100, Apple, Tesla and major markets
[Video]
1,54 %
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (ZAR) | jun. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 11,78 mrd. | 9,30 % |
Stroški poslovanja | 2,36 mrd. | −3,24 % |
Čisti dohodek | 1,04 mrd. | −18,17 % |
Čista dobičkovnost prihodkov | 8,87 | −25,15 % |
Earnings per share | — | — |
EBITDA | 2,93 mrd. | 7,80 % |
Efektivna davčna stopnja | 25,52 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (ZAR) | jun. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 12,34 mrd. | 13,06 % |
Skupna sredstva | 139,16 mrd. | 3,63 % |
Skupne obveznosti | 54,29 mrd. | 13,00 % |
Celoten lastniški kapital | 84,86 mrd. | — |
Shares outstanding | 444,21 mio. | — |
Razmerje P/B | 0,89 | — |
Donosnost sredstev | 4,84 % | — |
Donosnost kapitala | 5,56 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (ZAR) | jun. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 1,04 mrd. | −18,17 % |
Denar iz dejavnosti | 1,88 mrd. | −1,21 % |
Denar iz naložb | −1,65 mrd. | −79,92 % |
Denar iz financiranja | −141,50 mio. | 52,91 % |
Neto sprememba denarnih sredstev | −200,00 mio. | −118,37 % |
Prost denarni tok | 525,31 mio. | −32,86 % |
Vizitka
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
Generalni direktor
Datum ustanovitve
1850
Sedež organizacije
Spletno mesto
Zaposleni
9.109
